In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sequenom's Failure Highlights an Underappreciated Risk of Biotech Investing

Executive Summary

Sequenom's late April announcement that the R&D data associated with its soon-to-be-launched test for Down syndrome "was mishandled by individuals in our company" sent a cold shiver throughout the biotech investment community. As if the biotech investment model wasn't risky enough, the firm had to go and introduce a new one.
Advertisement

Related Content

Top Device Stories of 2009: A Year of Economic Revival and Regulatory Risk
Top Device Stories of 2009: A Year of Economic Revival and Regulatory Risk
Noninvasive Prenatal Diagnostics: How Much Closer to Reality?
Noninvasive Prenatal Diagnostics: How Much Closer to Reality?
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q2 2009
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q1 2009
Exact Sciences Buys Time with Genzyme Deal
Exact Sciences Buys Time with Genzyme Deal
Sequenom Is Improving Prenatal Screening, in Steps
Sequenom Is Improving Prenatal Screening, in Steps

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003310

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel